Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
21 hedge funds and large institutions have $3.46M invested in Ocean Biomedical, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 18 closing their positions.
598% more call options, than puts
Call options by funds: $286K | Put options by funds: $41K
27% less capital invested
Capital invested by funds: $4.77M → $3.46M (-$1.31M)
42% less funds holding
Funds holding: 36 → 21 (-15)
83% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 18
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$35.2K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.9K |
| 3 |
NA
Nordwand Advisors
Radnor,
Pennsylvania
|
+$2.14K |
| 4 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$74 |
| 5 |
FFA
Farther Finance Advisors
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$79.3K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$71K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$55.1K |
| 4 |
Millennium Management
New York
|
-$43.5K |
| 5 |
Jane Street
New York
|
-$42.3K |
OCEA Hedge Fund Activity: Q3 2024 in Review
21 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q3 2024, worth a combined $3.46M — down 27% from $4.77M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of OCEA and 3 opened new positions — a net loss of 15 holders — while 12 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $35.2K. The largest seller was Goldman Sachs, exiting entirely with an estimated $79.3K sold.
- 21 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q3 2024, down from 36 in Q2 2024.
- Funds reported $3.46M of Ocean Biomedical, Inc. Common Stock stock for Q3 2024, down 27% quarter-over-quarter.
- 3 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q3 2024 and 18 closed out, a net change of -15 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q3 2024 was Citadel Advisors, an estimated $35.2K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q3 2024 was Goldman Sachs, an estimated $79.3K sold.
Based on aggregated 13F filings for Q3 2024.